deltatrials
Completed PHASE2 NCT00917488

Glycyphagus Domesticus Allergen Extract. Determination of the in Vivo Biological Activity in Histamine Equivalent Units (HEP).

Sponsor: Laboratorios Leti, S.L.

Updated 6 times since 2017 Last updated: Jun 17, 2011 Started: May 31, 2009 Primary completion: May 31, 2010 Completion: Jul 31, 2010

A PHASE2 clinical study on Conjunctivitis, Allergic and Rhinitis, Allergic, Seasonal, this trial is completed. The trial is conducted by Laboratorios Leti, S.L. and has accumulated 6 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

6 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

Show 1 earlier version
  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

May 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Laboratorios Leti, S.L.
Data source: Laboratorios Leti, S.L.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • Cadiz, Spain